Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta
Trial details
- Registry ID
- NCT05768854
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis ImperfectaNCT05768854 | RARE | Phase 3 | Active not recruiting | 2025-10-23Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |